Nkgen BiotechNKGN
13F holders, Q1 2024 (March 31)13holders
$1.88avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Nkgen Biotech Inc. (NKGN) in their 13F filings. The largest holders were Meteora Capital, LLC ($2.3M), Polar Asset Management Partners Inc. ($2.0M) and University of Chicago ($1.0M).
- Company
- Nkgen Biotech Inc.
- CUSIP
- 65488A101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $211K |
| Exits | 2 | $4.7M |
Ownership 13 holders
| Meteora Capital, LLC | 0.39% | Reduce -24.4% | 1,207,616 | $2.3M |
| Polar Asset Management Partners Inc. | 0.07% | No change | 1,080,000 | $2.0M |
| University of Chicago | 1.50% | No change | 550,000 | $1.0M |
| Vanguard Group Inc. | 0.00% | New | 53,804 | $102K |
| Geode Capital Management, LLC | 0.00% | Add +16.4% | 53,369 | $101K |
| Susquehanna International Group, LLP | 0.00% | New | 16,906 | $32K |
| Sequoia Financial Advisors, LLC | 0.00% | New | 16,000 | $30K |
| Northern Trust Corp. | 0.00% | No change | 15,722 | $30K |
| UBS Group AG | 0.00% | New | 11,089 | $21K |
| Towneley Capital Management, Inc / DE | 0.00% | New | 10,000 | $19K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,824 | $7K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 500 | $945 |
| Wells Fargo & Company | 0.00% | Add +2.1% | 48 | $91 |
"% of holder's portfolio" is NKGN's weight in each manager's 13F, not the share of Nkgen Biotech Inc. the manager owns.